Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Evaluation of the pharmacokinetics (PK) of SPR206 in subjects with normal renal function,
subjects with various degrees of renal insufficiency, and subjects with end-stage renal
disease (ESRD) receiving hemodialysis (HD) therapy.